期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 51, 期 7, 页码 2591-2593出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01562-06
关键词
-
The in vitro activities of CG400549, a novel FabI inhibitor, were compared to those of linezolid and commonly used antimicrobials against recent bacterial isolates. CG400549 had an MIC90 of 0.5 mu g/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据